174 related articles for article (PubMed ID: 18026193)
1. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
Lacey JV; Ioffe OB; Ronnett BM; Rush BB; Richesson DA; Chatterjee N; Langholz B; Glass AG; Sherman ME
Br J Cancer; 2008 Jan; 98(1):45-53. PubMed ID: 18026193
[TBL] [Abstract][Full Text] [Related]
2. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
Lacey JV; Sherman ME; Rush BB; Ronnett BM; Ioffe OB; Duggan MA; Glass AG; Richesson DA; Chatterjee N; Langholz B
J Clin Oncol; 2010 Feb; 28(5):788-92. PubMed ID: 20065186
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
4. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.
Jeong JY; Hwang SO; Lee B; Kim K; Kim YB; Park SH; Choi HY
PLoS One; 2020; 15(12):e0243064. PubMed ID: 33259545
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
7. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital.
Sirimusika N; Peeyananjarassri K; Suphasynth Y; Wootipoom V; Kanjanapradit K; Geater A
J Med Assoc Thai; 2014 Mar; 97(3):260-6. PubMed ID: 25123004
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of diagnosis of endometrial hyperplasia by curettage].
Lü W; Xie X; Ye D
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):816-8. PubMed ID: 11798974
[TBL] [Abstract][Full Text] [Related]
9. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
10. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.
Kurman RJ; Kaminski PF; Norris HJ
Cancer; 1985 Jul; 56(2):403-12. PubMed ID: 4005805
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
12. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
Lacey JV; Mutter GL; Ronnett BM; Ioffe OB; Duggan MA; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer Res; 2008 Jul; 68(14):6014-20. PubMed ID: 18632658
[TBL] [Abstract][Full Text] [Related]
13. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
[TBL] [Abstract][Full Text] [Related]
14. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
[TBL] [Abstract][Full Text] [Related]
15. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
Lacey JV; Chia VM; Rush BB; Carreon DJ; Richesson DA; Ioffe OB; Ronnett BM; Chatterjee N; Langholz B; Sherman ME; Glass AG
Int J Cancer; 2012 Oct; 131(8):1921-9. PubMed ID: 22290745
[TBL] [Abstract][Full Text] [Related]
16. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
17. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
18. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
[TBL] [Abstract][Full Text] [Related]
19. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.
Doherty MT; Sanni OB; Coleman HG; Cardwell CR; McCluggage WG; Quinn D; Wylie J; McMenamin ÚC
PLoS One; 2020; 15(4):e0232231. PubMed ID: 32343732
[TBL] [Abstract][Full Text] [Related]
20. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.
Li M; Song JL; Zhao Y; Wu SL; Liu HB; Tang R; Yan L
J Zhejiang Univ Sci B; 2017 Nov.; 18(11):1022-1025. PubMed ID: 29119739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
